Higher serum and synovial fluid levels of VEGF and its receptors, along with the correlations between its levels and disease activity, suggest that VEGF can be additionally used for a better view of disease activity, treatment response, future erosive patterns, and extra-articular involvement in RA patients [54,55,56,57]. This evidence concerns the gene VEGFA and rheumatoid arthritis.